Metirosine or metyrosine

This classification denotes a tyrosine hydroxylase inhibitor with the molecular formula C10H13NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier DOQ0J0TPF7, chemically known as l-tyrosine, alpha-methyl-, (-)- but generally known as metirosine, which bears US NIH Compound Identifier 12650. European Medicines Agency schedules Metirosine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08894MIG. The term METIROSINE is an International Non-Proprietary Name. World Health Organization schedules metirosine in its Anatomical Therapeutic Chemical (ATC) Classification. METIROSINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Metirosine or metyrosine bears US NLM identifiers UMLS ID C0886584 and NCI Concept Code C998. SMILES: C[C@@](CC1=CC=C(C=C1)O)(C(=O)O)N.